TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Innovotech ( (TSE:IOT) ) has issued an update.
Innovotech Inc. reported strong revenues for the second quarter of 2025, totaling $984,327, and half-year revenues of $2,142,512, despite a second quarter loss of $241,199 due to a one-time executive severance expense. The company acquired intangible assets from BDS Microbial Services Inc., expanding its service offerings and contributing to revenue growth. This acquisition aligns with Innovotech’s focus on long-term profitable growth and strengthens its market position by redirecting clients to its Keystone Labs division.
More about Innovotech
Innovotech Inc. is a diversified Canadian technology company engaged in specialized laboratory services, biotechnology businesses, and proprietary intellectual property. It operates several subsidiary companies, including Innovotech Labs Corporation, which provides antimicrobial testing devices and commercializes antimicrobial silver solutions, and Keystone Labs Inc., a DEL-accredited lab serving the Canadian pharmaceutical and industrial markets. Innovotech also holds a 60% stake in NouLifeSciences Inc., which focuses on antioxidant molecules with potential applications in cosmetics and medical conditions.
Average Trading Volume: 44,335
Technical Sentiment Signal: Strong Buy
Current Market Cap: C$12.02M
For an in-depth examination of IOT stock, go to TipRanks’ Overview page.